Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
8.20
+0.04 (0.49%)
Sep 18, 2026, 4:00 PM EDT - Market closed
Xeris Biopharma Holdings Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Buy Reiterates $12 | Buy | Reiterates | $12 | +46.34% | Sep 10, 2026 |
Unknown Analyst Oppenheimer No rating | Oppenheimer | Buy Reiterates $18 | Buy | Reiterates | $18 | +119.51% | Sep 10, 2026 |
| Piper Sandler | Piper Sandler | Hold Reiterates $8 | Hold | Reiterates | $8 | -2.44% | Sep 10, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $10 | Buy | Reiterates | $10 | +21.95% | Sep 10, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $12 → $16 | Buy | Reiterates | $12 → $16 | +95.12% | Sep 10, 2026 |
| Barclays | Barclays | Buy Maintains $12 | Buy | Maintains | $12 | +46.34% | Aug 20, 2026 |